{
    "clinical_study": {
        "@rank": "153051", 
        "acronym": "MIMS", 
        "arm_group": [
            {
                "arm_group_label": "Brief Education", 
                "arm_group_type": "Active Comparator", 
                "description": "Patients receive a brief educational packet along with treatment as usual"
            }, 
            {
                "arm_group_label": "MI-CBT Treatment", 
                "arm_group_type": "Experimental", 
                "description": "Patients receive five 20 minute phone sessions of motivational interviewing/cognitive behavioral therapy weekly along with a brief educational packet."
            }
        ], 
        "brief_summary": {
            "textblock": "As many as 50% of MS patients prematurely discontinue their disease modifying medications.\n      For this study, we will develop a telephone-based talk therapy intervention and then conduct\n      a randomized controlled trial.  Patients will be assigned to either 5 weekly 20 minute\n      telephone sessions of psychotherapy or a brief education control condition. We hypothesize\n      that patients undergoing phone therapy will be more likely to indicate they are interested\n      in resuming taking disease modifying medications than patients given brief education and\n      treatment as usual."
        }, 
        "brief_title": "Development of a Motivational Intervention to Improve Treatment Adherence in MS", 
        "completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Relapsing-remitting Multiple Sclerosis", 
        "condition_browse": {
            "mesh_term": [
                "Multiple Sclerosis", 
                "Sclerosis", 
                "Multiple Sclerosis, Relapsing-Remitting"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Diagnosis of relapsing remitting MS based on established guidelines\n\n          -  Previously discontinued recommended therapy\n\n          -  Provider recommendation for DMT re-initiation\n\n          -  At least 18 years of age\n\n          -  Access to a telephone\n\n          -  English speaking"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "August 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01925690", 
            "org_study_id": "0033769", 
            "secondary_id": "National MS Society"
        }, 
        "intervention": [
            {
                "arm_group_label": "MI-CBT Treatment", 
                "description": "A telephone based talk therapy discussing pros and cons of medication use in MS.", 
                "intervention_name": "Motivational Interviewing-Cognitive Behavioral Therapy (MI-CBT)", 
                "intervention_type": "Behavioral"
            }, 
            {
                "arm_group_label": [
                    "Brief Education", 
                    "MI-CBT Treatment"
                ], 
                "description": "Give patients a pamphlet discussing pros and cons of disease modifying therapies", 
                "intervention_name": "Brief Education", 
                "intervention_type": "Behavioral"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "Multiple Sclerosis", 
            "Disease modifying medication", 
            "Relapsing-Remitting MS", 
            "Motivational Interviewing", 
            "Telephone Counseling"
        ], 
        "lastchanged_date": "August 19, 2013", 
        "link": {
            "description": "Clinical Neuropsychology Lab Research", 
            "url": "https://sites.google.com/site/clinicalneuropsychologylab/contact-us"
        }, 
        "location": [
            {
                "contact": {
                    "last_name": "Lawrence Dreyfus, Ph.D.", 
                    "phone": "816-235-6302"
                }, 
                "facility": {
                    "address": {
                        "city": "Kansas City", 
                        "country": "United States", 
                        "state": "Missouri", 
                        "zip": "64110"
                    }, 
                    "name": "University of Missouri-Kansas City"
                }, 
                "investigator": {
                    "last_name": "Jared Bruce, PhD", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "email": "lstrober@kesslerfoundation.org", 
                    "last_name": "Lauren Strober, PhD"
                }, 
                "facility": {
                    "address": {
                        "city": "West Orange", 
                        "country": "United States", 
                        "state": "New Jersey", 
                        "zip": "07052"
                    }, 
                    "name": "Kessler Rehabillitation Institute"
                }, 
                "investigator": {
                    "last_name": "Lauren Strober", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }
        ], 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Development of a Motivational Intervention to Improve Treatment Adherence in MS", 
        "other_outcome": [
            {
                "description": "Whether there is increased self-reported motivation to take disease modifying therapies on a 1-10 likert-type scale.", 
                "measure": "Motivation/Readiness Qustionnaire", 
                "safety_issue": "No", 
                "time_frame": "10 weeks post-enrollment"
            }, 
            {
                "description": "Whether there is an increase in self-reported motivation to take disease modifying therapies on a 1-10 likert-type scale.", 
                "measure": "Motivation/Readiness Questionnaire", 
                "safety_issue": "No", 
                "time_frame": "5 weeks post-enrollment"
            }
        ], 
        "overall_contact": {
            "email": "brucejm@umkc.edu", 
            "last_name": "Jared Bruce, PhD", 
            "phone": "816-235-5429"
        }, 
        "overall_official": {
            "affiliation": "University of Missouri, Kansas City", 
            "last_name": "Jared M Bruce, Ph.D.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Whether the patient indicates if he/she decided to re-initiate disease modifying therapies on a \"yes\"/\"no\" question.", 
            "measure": "Adherence Treatment Survey", 
            "safety_issue": "No", 
            "time_frame": "10 weeks after enrollment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01925690"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Missouri, Kansas City", 
            "investigator_full_name": "Jared Bruce", 
            "investigator_title": "Associate Professor of Psychology", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Whether the patient reports that he/she plans to discuss disease modifying therapies with a care provider on a \"yes\"/\"no\" question.", 
                "measure": "Adherence Treatment Survey", 
                "safety_issue": "No", 
                "time_frame": "10 weeks after enrollment"
            }, 
            {
                "description": "Whether the patient reports that he/she plans to discuss disease modifying therapies with a care provider on a \"yes\"/\"no\" question.", 
                "measure": "Adherence Treatment Survey", 
                "safety_issue": "No", 
                "time_frame": "5 weeks after enrollment"
            }, 
            {
                "description": "Whether the patient indicates if he/she decided to re-initiate disease modifying therapies on a \"yes\"/\"no\" question.", 
                "measure": "Adherence Treatment Survey", 
                "safety_issue": "No", 
                "time_frame": "5 weeks after enrollment"
            }
        ], 
        "source": "University of Missouri, Kansas City", 
        "sponsors": {
            "collaborator": {
                "agency": "National Multiple Sclerosis Society", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "University of Missouri, Kansas City", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2013", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "August 2013"
    }
}